Therapeutic Options for Retinoblastoma
Open Access
- 1 April 2016
- journal article
- research article
- Published by SAGE Publications in Cancer Control
- Vol. 23 (2) , 99-109
Abstract
Retinoblastoma is the most common primary intraocular malignancy in children. The management of retinoblastoma is complex and depends on several factors. This review provides an update on current and emerging therapeutic options for retinoblastoma. The medical literature was searched for articles relevant to the management of retinoblastoma. The results of prospective and retrospective studies on chemotherapy and focal therapy for retinoblastoma are summarized. Animal models for novel therapeutic agents are also discussed. Treatment strategies for retinoblastoma involve intravenous chemoreduction, local administration routes of chemotherapy (eg, intra-arterial, intravitreal), focal therapy for tumor consolidation (eg, photocoagulation, thermotherapy, cryotherapy, plaque brachytherapy), external beam radiotherapy, and surgical enucleation. Emerging therapies include alternative chemotherapeutic agents, molecularly targeted therapies, and novel drug-delivery systems. In the past 10 years, the management strategy for retinoblastoma has significantly changed, shifting toward local chemotherapy and away from systemic chemotherapy. Innovations in the field of molecular biology and the development of targeted therapies have led to improvements in survival rates and ocular salvage for this disease. However, the need still exists to further assess the long-term effects of such directional changes in therapy.Keywords
This publication has 100 references indexed in Scilit:
- Intravitreal chemotherapy for vitreous seeding in retinoblastoma: Recent advances and perspectivesSaudi Journal of Ophthalmology, 2013
- Targeted Administration into the Suprachoroidal Space Using a Microneedle for Drug Delivery to the Posterior Segment of the EyeInvestigative Ophthalmology & Visual Science, 2012
- Understanding pRb: toward the necessary development of targeted treatments for retinoblastomaJournal of Clinical Investigation, 2012
- Residual Intraretinal Retinoblastoma After Chemoreduction FailureArchives of Ophthalmology (1950), 2012
- A novel retinoblastoma therapy from genomic and epigenetic analysesNature, 2012
- Targeting the p53 Pathway in Retinoblastoma with Subconjunctival Nutlin-3aCancer Research, 2011
- In Vitro Evaluation of a Targeted and Sustained Release System for Retinoblastoma Cells Using Doxorubicin as a Model DrugJournal of Ocular Pharmacology and Therapeutics, 2010
- Gold nanocages covered by smart polymers for controlled release with near-infrared lightNature Materials, 2009
- Subconjunctival Nanoparticle Carboplatin in the Treatment of Murine RetinoblastomaArchives of Ophthalmology (1950), 2009
- Survival with retinoblastoma in the USA: 1975-2004British Journal of Ophthalmology, 2008